Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Hardcover, 1st ed. 2018)

This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.

General

Imprint:	Springer International Publishing AG
Country of origin:	Switzerland
Series:	Resistance to Targeted Anti-Cancer Therapeutics, 15
Release date:	April 2018
First published:	2018
Editors:	Yosef Yarden • Moshe Elkabets
Dimensions:	235 x 155mm (L x W)
Format:	Hardcover
Pages:	242
Edition:	1st ed. 2018
ISBN-13:	978-3-319-67930-3
Categories:	Books > Medicine > General issues > Medical equipment & techniques > Medical research Books > Medicine > Other branches of medicine > Pharmacology > General Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN:	3-319-67930-9
Barcode:	9783319679303

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!